JP2022518495A5 - - Google Patents
Info
- Publication number
- JP2022518495A5 JP2022518495A5 JP2021542362A JP2021542362A JP2022518495A5 JP 2022518495 A5 JP2022518495 A5 JP 2022518495A5 JP 2021542362 A JP2021542362 A JP 2021542362A JP 2021542362 A JP2021542362 A JP 2021542362A JP 2022518495 A5 JP2022518495 A5 JP 2022518495A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharmaceutical composition
- composition according
- compound represented
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795899P | 2019-01-23 | 2019-01-23 | |
| US62/795,899 | 2019-01-23 | ||
| PCT/US2020/014818 WO2020154519A2 (en) | 2019-01-23 | 2020-01-23 | Methods of treating addiction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518495A JP2022518495A (ja) | 2022-03-15 |
| JP2022518495A5 true JP2022518495A5 (https=) | 2023-01-26 |
| JP7555343B2 JP7555343B2 (ja) | 2024-09-24 |
Family
ID=71735540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542362A Active JP7555343B2 (ja) | 2019-01-23 | 2020-01-23 | 嗜癖の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220088014A1 (https=) |
| EP (1) | EP3914235A4 (https=) |
| JP (1) | JP7555343B2 (https=) |
| KR (1) | KR102928755B1 (https=) |
| CN (2) | CN118105390A (https=) |
| AU (1) | AU2020212019B2 (https=) |
| CA (1) | CA3125777A1 (https=) |
| IL (1) | IL284797A (https=) |
| MX (2) | MX2021008717A (https=) |
| WO (1) | WO2020154519A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3838274T3 (pl) | 2016-01-26 | 2024-04-02 | Intra-Cellular Therapies, Inc. | Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN |
| JP7520013B2 (ja) | 2018-12-17 | 2024-07-22 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 置換複素環縮合γ－カルボリンの合成 |
| IL315005B2 (en) | 2018-12-17 | 2026-04-01 | Intra Cellular Therapies Inc | Synthesis of condensed gamma-carbolines and converted heterocycles |
| JP7649743B2 (ja) | 2018-12-21 | 2025-03-21 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| MX2024004725A (es) * | 2021-10-19 | 2024-05-10 | Intra Cellular Therapies Inc | Metodos novedosos. |
| CN116210637A (zh) * | 2021-12-06 | 2023-06-06 | 中国科学院深圳先进技术研究院 | 一种成瘾药物戒断后复吸相关调控基因及其筛选方法 |
| WO2024145659A1 (en) * | 2022-12-30 | 2024-07-04 | Intra-Cellular Therapies, Inc. | Heterocycle fused gamma-carbolines acting on the serotonine 5-ht2a receptor |
| WO2025257090A1 (en) | 2024-06-10 | 2025-12-18 | Interquim, S.A. | Process for the preparation of synthesis intermediates of lumateperone and lumateperone analogues |
| CN119912455B (zh) * | 2025-01-22 | 2025-09-23 | 成都臻拓医药科技有限公司 | 一种卢美哌隆中间体化合物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE277048T1 (de) * | 1999-06-15 | 2004-10-15 | Bristol Myers Squibb Pharma Co | Substituierte hetercyclisch kondensierte gamma carboline |
| PL3838274T3 (pl) * | 2016-01-26 | 2024-04-02 | Intra-Cellular Therapies, Inc. | Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN |
| WO2018126140A1 (en) * | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| EP3562484B1 (en) * | 2016-12-29 | 2021-08-25 | Intra-Cellular Therapies, Inc. | Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders |
| EP3658144B1 (en) * | 2017-07-26 | 2022-01-26 | Intra-Cellular Therapies, Inc. | Pyridopyrroloquinoxaline compounds, their compositions and uses in therapy |
| WO2019023062A1 (en) * | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| EP3801527B1 (en) * | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| JP7649743B2 (ja) * | 2018-12-21 | 2025-03-21 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
-
2020
- 2020-01-23 CN CN202311661516.6A patent/CN118105390A/zh active Pending
- 2020-01-23 MX MX2021008717A patent/MX2021008717A/es unknown
- 2020-01-23 KR KR1020217026674A patent/KR102928755B1/ko active Active
- 2020-01-23 MX MX2025009723A patent/MX2025009723A/es unknown
- 2020-01-23 JP JP2021542362A patent/JP7555343B2/ja active Active
- 2020-01-23 AU AU2020212019A patent/AU2020212019B2/en active Active
- 2020-01-23 CA CA3125777A patent/CA3125777A1/en active Pending
- 2020-01-23 US US17/425,641 patent/US20220088014A1/en not_active Abandoned
- 2020-01-23 CN CN202080010604.8A patent/CN113329742A/zh active Pending
- 2020-01-23 WO PCT/US2020/014818 patent/WO2020154519A2/en not_active Ceased
- 2020-01-23 EP EP20745504.9A patent/EP3914235A4/en active Pending
-
2021
- 2021-07-12 IL IL284797A patent/IL284797A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022518495A5 (https=) | ||
| US12195445B2 (en) | 2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors | |
| TWI827037B (zh) | 作為nav1.8抑制劑之環烷基3-側氧基哌甲醯胺及環雜烷基3-側氧基哌甲醯胺 | |
| TWI623325B (zh) | 四級銨鹽前藥 | |
| US12516046B2 (en) | 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors | |
| JP7757284B2 (ja) | Ｅｇｆｒの分解のためのイソインドリノン及びインダゾール化合物 | |
| KR102922472B1 (ko) | Nav1.8 억제제로서의 2-옥소이미다졸리딘-4-카르복스아미드 | |
| JP7846132B2 (ja) | Ｎａｖ１．８阻害薬としてのアリール ３－オキソピペラジンカルボキサミド類及びヘテロアリール ３－オキソピペラジンカルボキサミド類 | |
| CN115697327A (zh) | 作为nav1.8抑制剂的5-氧代-吡咯烷-3-甲酰胺 | |
| CA3181676A1 (en) | Imidazopyridazines as modulators of il-17 | |
| JP2010510328A (ja) | ７，８−飽和−４，５−エポキシ−モルフィナニウム類似体の（ｒ）−ｎ−立体異性体 | |
| JP2007515446A5 (https=) | ||
| KR20200046053A (ko) | 스피로사이클 화합물 및 이를 제조하고 사용하는 방법 | |
| US7164021B2 (en) | Opiate analogs selective for the δ-opioid receptor | |
| CN103533937A (zh) | 杂合阿片样化合物和组合物 | |
| JP2010510326A (ja) | ４，５−エポキシ−モルフィナニウム類似体のｎ−オキシド類 | |
| HUE027000T2 (en) | Compounds with muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| JP2020502047A (ja) | Ｍａｇｌ阻害剤 | |
| UA128288C2 (uk) | СПОЛУКИ АМІНОПІРАЗИНДІОЛУ ЯК ІНГІБІТОРИ PI3K-<font face="Symbol">g</font> | |
| TW200918057A (en) | 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists | |
| AU2012335980A1 (en) | Modulators of opioid receptors and methods of use thereof | |
| JP2012514654A (ja) | フッ素含有化合物およびその使用法 | |
| US20110112129A2 (en) | Peripheral Phenolic Opioid Antagonist | |
| JP2006527236A (ja) | オピオイド鎮痛薬と組合せた置換１，４−ジ−ピペリジン−４−イル−ピペラジン誘導体ならびに疼痛およびオピオイドに基づく処置に伴う副作用の処置のためのそれらの使用 | |
| JP4588444B2 (ja) | ジアザビシクロノナン及び−デカン誘導体並びにこれをオピオイドレセプターリガンドとして使用する方法 |